Dockets

Federal rulemakings, soonest-closing first — each gathers its documents and comments.

NonrulemakingFTA

Charter Server Complaints

12
documents
8
comments
Last activity Jul 8, 2026View docket →
NonrulemakingFAA

Matthew T. Keefe - Exemption/Rulemaking

2
documents
53
comments
Last activity Jul 7, 2026View docket →
NonrulemakingFAA

Amor Fati Industries Corp. - Exemption/Rulemaking

3
documents
2
comments
Last activity Jul 6, 2026View docket →
NonrulemakingFDA

Requests that the FDA initiate rulemaking to establish a clear, enforceable regulatory definition and substantiation requirements for the animal-raising claim “pasture-raised” as applied to shell eggs from laying hens.

2
documents
1.6K
comments
Last activity Jul 4, 2026View docket →
NonrulemakingNHTSA

Federal Registers for Applications, Notices, and Orders - Miscellaneous

4
documents
6
comments
Last activity Jul 3, 2026View docket →
NonrulemakingFAA

NetJets Aviation, Inc - Exemption/Rulemaking

4
documents
32
comments

1 awaiting analysis

Last activity Jul 2, 2026View docket →
NonrulemakingFDA

Requesting that the FDA make changes to an existing Guidance for Industry requirement by amending the regulation in this way: 10. How are Spices, natural flavors or artificial flavors declared in ingredients lists Answer: These may be declared in ingredient lists by using either specific common or scientific names. All products or ingredients of products that are spices

1
document
1
comments
Last activity Jul 2, 2026View docket →
NonrulemakingFDA

Requests that the FDA to remove oral diphenhydramine from all over-the counter cough, cold and allergy products.

3
documents
2
comments
Last activity Jul 2, 2026View docket →
NonrulemakingFDA

Request that FDA remove the Mifepristone Shared System REMS Program, including but not limited to the three ETASU requiring prescriber certification, pharmacy certification, and a patient agreement form

1
document
247
comments
Last activity Jul 1, 2026View docket →
NonrulemakingFDA

Request that the FDA remove the Mifepristone REMS Program, including but not limited to the Prescriber Certification, Pharmacy Certification, and Patient Agreement form

1
document
155
comments
Last activity Jul 1, 2026View docket →
NonrulemakingFDA

Requests that absent new peer-reviewed studies or otherwise robust scientific or clinical evidence warranting such action, FDA take no action that would reduce patient access to mifepristone and/or increase the burdens associated with prescribing or dispensing mifepristone.

1
document
120
comments
Last activity Jul 1, 2026View docket →
NonrulemakingFAA

Adam Kleinschmit - Exemption/Rulemaking

4
documents
1
comments
Last activity Jun 30, 2026View docket →